financetom
Business
financetom
/
Business
/
Market Chatter: Activist Browning West Takes 4% CAE Stake to Sway CEO Succession
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Activist Browning West Takes 4% CAE Stake to Sway CEO Succession
Dec 20, 2024 7:59 AM

10:37 AM EST, 12/20/2024 (MT Newswires) -- Investment firm Browning West LP has built a 4.3% interest in Quebec-based flight simulator company CAE Inc. ( CAE ) and wants a say in picking its next chief executive officer, Bloomberg is reporting on Friday.

It noted the Los Angeles-based money manager sent a letter to CAE's board on Friday, complimenting the company's "enviable market position" but stressing that it has underperformed. CEO Marc Parent recently announced his retirement after 15 years.

The choice of CAE's next boss is "critical" to realize its potential, Browning West partners Usman Nabi and Peter Lee wrote, urging directors "not to act hastily in its CEO search, but rather to engage with us to collectively recruit the best possible leader."

CAE said in November that Parent will leave at the next annual shareholder meeting, scheduled for August. Its shares have slipped about 4% over the last five years versus a 43% rise in the S&P/TSX Composite Index over the same period.

Browning West, founded in 2019, is fresh off a high-profile activist win in Canada. In May, it triumphed in a dramatic campaign at Montreal-based apparel-maker Gildan Activewear Inc., gaining control of the board in a proxy fight and bringing back its longtime CEO.

Spokespeople for CAE did not immediately respond to a request for comment.

(Market Chatter news is derived from conversations with market professionals globally, and/or from other media sources. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 33.45, Change: +0.59, Percent Change: +1.80

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved